06.11.2018
Improve Outcomes
$985,855.00
59 months
Understanding the Impact of Rapid Acting Analog Differences on Glucose Control
Funding to investigate the impact of various rapid acting insulin analogs on glucose control via an automated insulin delivery (AID) system and to determine whether glucose control differences between analogs can be predicted by the presence of analog-specific anti-insulin antibodies.